Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v31-FR Version v15-FR
Language French French
Date Updated 2020-07-31 2019-09-26
Drug Identification Number 02456885 02456885
Brand name MYLAN-ATAZANAVIR MYLAN-ATAZANAVIR
Common or Proper name ATAZANAVIR ATAZANAVIR
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients ATAZANAVIR ATAZANAVIR
Strength(s) 200MG 200MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL
Packaging size 60 BT 60 BT
ATC code J05AE J05AE
ATC description DIRECT ACTING ANTIVIRALS DIRECT ACTING ANTIVIRALS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2019-02-26 2019-02-26
Actual start date 2019-03-05 2019-03-05
Estimated end date 2020-07-28 Unknown
Actual end date 2020-07-17
Shortage status Resolved Actual shortage
Company comments
Health Canada comments